The content on this site is intended for healthcare professionals only
Dr Palladini talks to ecancertv at ICMM 2016 about screening for amyloidosis, to prevent people being mistakenly treated for cancer.
Because amyloidosis is rare, he says, it can be overlooked as a possibility and people can undergo futile chemotherapy.
ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content
ASCO 2026: Latest updates in mRCC
New classification for identifying HR myeloma based on cytogenetic abnormalities
Revolutionising myeloma treatment through immune profiling
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
SABCS 2023: Latest breast cancer diagnostics guidelines
Relapsed refractory multiple myeloma
